Epithelial expression and function of trypsin-3 in irritable bowel syndrome

Gut. 2017 Oct;66(10):1767-1778. doi: 10.1136/gutjnl-2016-312094. Epub 2017 Jan 17.

Abstract

Objectives: Proteases are key mediators of pain and altered enteric neuronal signalling, although the types and sources of these important intestinal mediators are unknown. We hypothesised that intestinal epithelium is a major source of trypsin-like activity in patients with IBS and this activity signals to primary afferent and enteric nerves and induces visceral hypersensitivity.

Design: Trypsin-like activity was determined in tissues from patients with IBS and in supernatants of Caco-2 cells stimulated or not. These supernatants were also applied to cultures of primary afferents. mRNA isoforms of trypsin (PRSS1, 2 and 3) were detected by reverse transcription-PCR, and trypsin-3 protein expression was studied by western blot analysis and immunohistochemistry. Electrophysiological recordings and Ca2+ imaging in response to trypsin-3 were performed in mouse primary afferent and in human submucosal neurons, respectively. Visceromotor response to colorectal distension was recorded in mice administered intracolonically with trypsin-3.

Results: We showed that stimulated intestinal epithelial cells released trypsin-like activity specifically from the basolateral side. This activity was able to activate sensory neurons. In colons of patients with IBS, increased trypsin-like activity was associated with the epithelium. We identified that trypsin-3 was the only form of trypsin upregulated in stimulated intestinal epithelial cells and in tissues from patients with IBS. Trypsin-3 was able to signal to human submucosal enteric neurons and mouse sensory neurons, and to induce visceral hypersensitivity in vivo, all by a protease-activated receptor-2-dependent mechanism.

Conclusions: In IBS, the intestinal epithelium produces and releases the active protease trypsin-3, which is able to signal to enteric neurons and to induce visceral hypersensitivity.

Keywords: ABDOMINAL PAIN; IRRITABLE BOWEL SYNDROME; NERVE - GUT INTERACTIONS; TRYPSIN.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Caco-2 Cells
  • Case-Control Studies
  • Colon / enzymology
  • Colon / innervation
  • Culture Media, Conditioned / pharmacology
  • Dipeptides / pharmacology
  • Enteric Nervous System / cytology
  • Enteric Nervous System / diagnostic imaging
  • Enteric Nervous System / drug effects
  • Epithelial Cells / drug effects
  • Epithelial Cells / enzymology*
  • Female
  • Ganglia, Spinal / cytology
  • Humans
  • Hypersensitivity / enzymology
  • Intestinal Mucosa / drug effects
  • Intestinal Mucosa / enzymology*
  • Intestinal Mucosa / pathology
  • Irritable Bowel Syndrome / enzymology*
  • Irritable Bowel Syndrome / genetics*
  • Isoxazoles / pharmacology
  • Lipopolysaccharides / pharmacology
  • Male
  • Mice
  • Microscopy, Confocal
  • Neurons, Afferent / drug effects
  • Neurons, Afferent / physiology
  • Permeability / drug effects
  • RNA, Messenger / analysis
  • Rats
  • Receptor, PAR-2 / antagonists & inhibitors
  • Receptor, PAR-2 / metabolism
  • Trypsin / genetics*
  • Trypsin / metabolism*
  • Trypsin / pharmacology
  • Trypsinogen / genetics
  • Up-Regulation

Substances

  • 5-isoxazoyl-cyclohexylalanyl-isoleucyl-spiroindane-1,4'-piperidine
  • Culture Media, Conditioned
  • Dipeptides
  • Isoxazoles
  • Lipopolysaccharides
  • RNA, Messenger
  • Receptor, PAR-2
  • PRSS2 protein, human
  • Trypsinogen
  • PRSS1 protein, human
  • PRSS3 protein, human
  • PRSS3 protein, mouse
  • Trypsin